Patents by Inventor George Guittard

George Guittard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the Management of Incontinence
    Publication number: 20080021102
    Abstract: A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
    Type: Application
    Filed: July 25, 2007
    Publication date: January 24, 2008
    Applicant: Alza Corporation
    Inventors: George Guittard, Francisco Jao, Susan Marks, David Kidney, Fernando Gumucio, Suneel Gupta, Gayatri Sathyan
  • Compositions and dosage forms for enhanced absorption
    Publication number: 20060094782
    Abstract: Disclosed is controlled delivery of pharmaceutical agents and methods, dosage forms and devices therefore. In particular, formulation, dosage forms, methods and devices for enhanced absorption and controlled delivery drug compounds are disclosed.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 4, 2006
    Inventors: Patrick Wong, Dong Yan, George Guittard
  • Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
    Publication number: 20050163848
    Abstract: A complex comprised of gabapentin or pregabalin and a transport moiety, such as an alkyl sulfate, is described. The complex has an enhanced absorption in the gastrointestinal tract, particularly the lower gastrointestinal tract. The complex, and compositions and dosage forms prepared using the complex, provide for absorption by the body of the drug through a period of ten to twenty-four hours, thus enabling a once-daily dosage form for gabapentin or pregabalin.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Patrick Wong, Dong Yan, George Guittard
  • Compositions and dosage forms for enhanced absorption
    Publication number: 20050165102
    Abstract: Disclosed is controlled delivery of pharmaceutical agents and methods, dosage forms and devices therefore. In particular, formulation, dosage forms, methods and devices for enhanced absorption and controlled delivery drug compounds are disclosed.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Patrick Wong, Dong Yan, George Guittard
  • Compositions and dosage forms for enhanced absorption of iron
    Publication number: 20050163849
    Abstract: A complex comprised of iron and a transport moiety, such as a fatty acid, is described. The complex has an enhanced absorption in the gastrointestinal tract, particularly the lower gastrointestinal tract. The complex, and compositions and dosage forms prepared using the complex, provide for absorption by the body of iron through a period of ten to twenty-four hours, thus enabling a true once-daily dosage form for iron.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Patrick Wong, Dong Yan, George Guittard
  • Administration of levodopa and carbidopa
    Publication number: 20050163850
    Abstract: Disclosed are substances, compositions, dosage forms and methods that comprise levodopa and/or carbidopa.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Patrick Wong, Dong Yan, Stephen Hwang, George Guittard
  • Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
    Publication number: 20050163841
    Abstract: Disclosed are substances, compositions, dosage forms and methods relating to drugs including 3-aminopropyl-n-butyl-phosphinic acid; structural homologs thereof; 3-aminopropyl-n-butyl-phosphinic acid complexes; complexes that comprise structural homologs of 3-aminopropyl-n-butyl-phosphinic acid; pharmaceutically acceptable salts of 3-aminopropyl-n-butyl-phosphinic acid or structural homologs thereof; and mixtures of the above.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 28, 2005
    Inventors: Patrick Wong, Dong Yan, Andrew Lam, Stephen Hwang, George Guittard
  • Compositions and dosage forms for enhanced absorption of metformin
    Publication number: 20050158374
    Abstract: A complex comprised of metformin and a transport moiety, such as a fatty acid, is described. The complex has an enhanced absorption in the gastrointestinal tract, particularly the lower gastrointestinal tract. The complex, and compositions and dosage forms prepared using the complex, provide for absorption by the body of the drug through a period of ten to twenty-four hours, thus enabling a once-daily dosage form for metformin.
    Type: Application
    Filed: October 29, 2004
    Publication date: July 21, 2005
    Inventors: Patrick Wong, Dong Yan, George Guittard